#VisualAbstract: SGLT2 inhibitors reduce recurrent flares and hospitalizations in patients with gout
In this population cohort study, patients with gout who used sodium-glucose cotransporter-2 inhibitors (SGLT2is) experienced fewer recurrent flares than those ...